Some lawmakers are urging the Trump administration to rethink a pending rule that may prevent Americans from obtaining ...
A new study in mice led by Washington University in St. Louis researchers suggests that stopping certain immune cells from ...
The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to ...
At a MAHA Institute event, Kennedy and others argued that health data should be more accessible to researchers can study ...
Senate’s health committee doesn’t have a vote scheduled on the nominee to run the FDA.
UniQure's gene therapy continues to slow Huntington's progression after four years. But the magnitude of the benefit waned ...
Post-wildfire air quality needs to be monitored long term, suggests a study finding Maui residents had high levels of toxic ...
Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.
The Trump administration asked the Supreme Court on Monday to let it enforce, for now, restrictions on gender-affirming care ...
Defenses against AI-created bioweapons will take years to build. We don’t have years to spare,” writes Ashish Jha.
Late Friday night, the Trump administration clawed back nearly $1 billion in spending approved by Congress, targeting several ...
The FDA has approved AbbVie’s once-daily Parkinson’s pill for sales, based on a late-stage study that showed the drug helped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results